INO: Inovio Pharmaceuticals Inc

INO新闻

• 15:42 NVO's Etavopivat Hits Key Goals in Phase III Sickle Cell Disease Study
• 12:35 Viking Therapeutics Gears Up for Q1 Earnings: Here's What to Expect
• 14:28 NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program
• 14:37 TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication
• 14:31 Inovio: "Hold" As Upcoming PDUFA For INO-3107 Is Major Inflection Point (NASDAQ:INO)
• 13:35 Inovio (INO) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
• 16:08 Novo Nordisk's Awiqli Gets FDA Approval for Type II Diabetes
• 16:06 KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate
• 17:14 SRPT Stock Surges on Promising Early Results From siRNA Programs
• 15:06 BEAM Eyes Global Expansion of AATD Study After Strong Early Data
• 16:24 NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data
• 14:08 Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
• 14:26 APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy
• 13:55 Here's Why Inovio (INO) Looks Ripe for Bottom Fishing
• 14:05 PFE Talzenna Combo Shows Strong Efficacy in Wider Prostate Cancer Use
• 12:10 FDA Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients
• 11:46 H.C. Wainwright维持Inovio股票评级,关注FDA审查
• 11:44 H.C. Wainwright reiterates Inovio stock rating on FDA review
• 14:41 Inovio Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:INO) 2026-03-13
• 11:58 Oppenheimer维持Inovio制药"跑赢大盘"评级,关注加速审批途径
• 11:56 Inovio stock maintains Outperform rating at Oppenheimer on AA pathway
• 10:32 Inovio Stock Up On Earnings, Pipeline Progress - Inovio Pharmaceuticals (NASDAQ:INO)
• 01:52 Inovio Pharmaceuticals, Inc. (INO) Q4 2025 Earnings Call Transcript
• 02:36 港股异动 | 康方生物-B(09926)早盘涨超6% 联合美国INOVIO新型DNA药物探索胶质母细胞瘤创新治疗